Synchrony Financial (NYSE:SYF – Get Free Report) was downgraded by stock analysts at Evercore from an “outperform” rating to a “hold” rating in a research note issued to investors on Wednesday, Marketbeat.com reports. They presently have a $78.00 target price on the financial services provider’s stock. Evercore’s price target would indicate a potential upside of 5.23% from the stock’s current price.
Several other equities analysts have also recently commented on SYF. Morgan Stanley lowered their price target on shares of Synchrony Financial from $84.00 to $83.00 and set an “equal weight” rating on the stock in a report on Monday, October 12th. Jefferies Financial Group reaffirmed a “buy” rating and issued a $103.00 price target on shares of Synchrony Financial in a research note on Tuesday. Robert W. Baird increased their price objective on Synchrony Financial from $86.00 to $90.00 and gave the stock an “outperform” rating in a report on Wednesday, July 22nd. UBS Group reduced their price objective on Synchrony Financial from $87.00 to $81.00 and set a “neutral” rating for the company in a research report on Monday, October 5th. Finally, Royal Bank Of Canada reaffirmed a “sector perform” rating on shares of Synchrony Financial in a research note on Tuesday. Ten research analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the company’s stock. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $87.83.
View Our Latest Analysis on Synchrony Financial
Synchrony Financial Stock Performance
Synchrony Financial (NYSE:SYF – Get Free Report) last released its quarterly earnings data on Tuesday, October 20th. The financial services provider reported $2.68 earnings per share for the quarter, beating the consensus estimate of $2.42 by $0.26. Synchrony Financial had a net margin of 14.59% and a return on equity of 22.26%. The firm had revenue of $3.82 billion for the quarter, compared to analyst estimates of $3.81 billion. During the same quarter in the prior year, the business earned $2.86 EPS. Research analysts anticipate that Synchrony Financial will post 9.50 earnings per share for the current fiscal year.
Institutional Trading of Synchrony Financial
Institutional investors and hedge funds have recently modified their holdings of the company. Pension & Wealth Management Advisors Inc. bought a new stake in shares of Synchrony Financial during the 3rd quarter worth $26,000. Compass Financial Management LLC acquired a new stake in shares of Synchrony Financial in the second quarter valued at about $29,000. GK Wealth Management LLC acquired a new stake in shares of Synchrony Financial in the third quarter valued at about $31,000. Center for Financial Planning Inc. grew its position in shares of Synchrony Financial by 242.9% in the first quarter. Center for Financial Planning Inc. now owns 480 shares of the financial services provider’s stock valued at $33,000 after purchasing an additional 340 shares during the last quarter. Finally, Fiduciary Financial Advisors bought a new position in shares of Synchrony Financial in the second quarter worth about $33,000. 96.48% of the stock is currently owned by institutional investors and hedge funds.
Key Stories Impacting Synchrony Financial
Here are the key news stories impacting Synchrony Financial this week:
- Positive Sentiment: Q3 earnings beat expectations: Synchrony reported adjusted earnings of $2.68 per share, above consensus estimates of roughly $2.42–$2.48, while revenue of $3.82 billion was approximately in line to slightly above expectations. Profit declined from $2.86 per share a year ago because of higher costs, but the results still exceeded forecasts. Synchrony Q3 Earnings Top Estimates
- Positive Sentiment: Credit quality improved: Net charge-offs fell to about 4.79%, while early-stage delinquencies stabilized or declined. The data eased fears of a major deterioration in retail consumer credit and supported management’s view that underwriting and risk controls remain effective. Synchrony Financial Profit Falls on Higher Costs but Credit Trends Improve
- Positive Sentiment: Guidance and spending were encouraging: Synchrony maintained FY 2026 EPS guidance at approximately $9.50, above the $9.44 consensus estimate. Third-quarter purchase volume rose 8% year over year to nearly $49.7 billion, indicating continued consumer spending. The company also announced a $0.34-per-share quarterly dividend.
- Positive Sentiment: Analyst support and strategic initiatives: Barclays raised its price target to $94 and retained an overweight rating, while Synchrony’s CareCredit Pay Later launch expands consumer financing options and could support future healthcare-related volume. CareCredit Introduces CareCredit Pay Later
- Neutral Sentiment: Mixed analyst signals: JPMorgan lifted its target to $77 but kept a neutral rating. Evercore downgraded SYF from outperform to in-line with a $78 target, citing higher rates and macroeconomic volatility. These actions may limit near-term upside despite the earnings beat.
- Negative Sentiment: Profitability pressures remain: Higher expenses and a modest contraction in net interest margin weighed on results. A higher customer payment rate may also slow the conversion of strong purchase volume into interest-earning loan growth.
Synchrony Financial Company Profile
Synchrony Financial (NYSE: SYF) is a consumer financial services company that provides private-label credit cards, co-branded credit cards and promotional financing programs. Its financing products are offered through retailers, manufacturers, healthcare providers and other businesses, helping consumers pay for purchases over time.
The company serves a range of industries, including digital commerce, home improvement, furniture, automotive, healthcare, jewelry, apparel, electronics and specialty retail.
Featured Stories
- Five stocks we like better than Synchrony Financial
- Are RTX Corporation and Northrop Grumman Ready to Break Out?
- GM Beat and Added a $20 Billion Buyback—Why Did the Stock Fall?
- Intercepting Growth: Karman Secures $218M Lockheed Martin Deal
- Tech Stocks Took a Hit—These 2 Pharma Stocks Are Near New Highs
Receive News & Ratings for Synchrony Financial Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synchrony Financial and related companies with MarketBeat.com's FREE daily email newsletter.
